August J. Troendle, a 10% owner and President & CEO, sold common stock in two transactions on July 27 and July 28, 2026, at reported weighted average prices of $600.85 and $600.01 per share respectively for a combined total sale amount of $4,346,003; following the reported transactions Troendle directly owns 638,946 common shares and indirectly owns 4,733,019 common shares via Medpace Investors, LLC.

Susan E. Burwig, an officer serving as Executive Vice President, Operations, sold 7,500 shares of common stock at $600.00 per share for a total sale amount of $4,500,000; following the transaction Burwig directly owns 62,984 shares of common stock and the form notes the sale was effected pursuant to a limit order placed by the reporting person during an open window period.

Reporter NameRelationshipTypeAmountSEC Filing
Troendle August J.President & CEO, 10% OwnerSell$4,346,003Burwig Susan EExec. VP, OperationsSell$4,500,000
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.